A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
In its research-grade form, it appears as a white lyophilized (freeze-dried) powder
Reduced Oxidative Stress: Helps the body manage inflammation and environmental stressors more effectively
They mimic a natural hormone which helps regulate appetite, blood sugar, and insulin levels
According to the researchers, up to 85.1% of those treated with survodutide achieved at least a 5% reduction in their weight, contrasting with only 38.8% in the placebo group who reached this goal
Concentration: Typically expressed as milligrams per milliliter (mg/mL)